MEDIZEN HUMANCARE Inc. (XKON: 236340)

Market Cap	8.07B
Revenue	n/a
Net Income	n/a
Shares Out	2.30M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	257
Open	3,800.00
Previous Close	3,600.00
Day's Range	3,500.00 - 3,800.00
52-Week Range	2,720.00 - 6,400.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About MEDIZEN HUMANCARE

MEDIZEN HUMANCARE Inc., a research company, engages in the genomic analysis to predict diseases on an individual basis in Asia, the Americas, Europe, and internationally. Its services include M-CHECK, which provides an analysis of patients’ risk for genetic diseases using genomic variation packages related to specific diseases with gene chips or analysis kits; and MELTHY (DTC), a DNA analysis service. The company was founded in 2012 and is based in Seoul, South Korea.

• Industry: Commercial Physical and Biological Research
• Founded: 2012
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 236340